MilliporeSigma and InnoCore Pharmaceuticals have entered into a global agreement to provide InnoCore’s SynBiosys biodegradable polymer platform, which is used to develop sustained release solutions for biologics in injectable formulations.   “Until now, formulating large biological active pharmaceutical ingredients such as proteins and large peptides into long-acting sustained release formulations has been difficult, if not impossible,” said Andrew Bulpin, head of Process Solutions at Millipor...